Bridge Neurotech, a startup developing a non-invasive brain-computer interface that images brain activity using ultrasound, has secured $13.5M in new investment. The company's approach bypasses the need for surgery or other physical modifications, positioning it as a notable player in the burgeoning field of direct neural interaction without invasive procedures.
The funding round drew support from General Catalyst, #reMindCapital, Sunflower Capital, and Scott Sandell. Bridge Neurotech is currently enrolling participants for its first research study, marking a significant step in bringing its technology to initial human trials.












